Health Blog with videos and articles
Cancer survival rates improve slightly
The long-term prognosis has generally improved for most types of cancer since the 1990s – sometimes markedly, according to new data from the Canadian Cancer Registry.
Read more on CBC Newfoundland and Labrador
Dendreon said its prostate cancer treatment Provenge prolonged patient survival, providing fuel for a rally in its shares.
Vandetanib extends Progression Free Survival in ZETA phase III study for advanced medullary thyroid cancer
Results from ZETA, a phase III study in patients with advanced medullary thyroid cancer (MTC), showed that treatment with the investigational drug vandetanib significantly extended Progression Free Survival (PFS), the primary endpoint of the study, by demonstrating a 54% reduction in the rate of progression compared to placebo.
Read more on News-Medical-Net
Hilarious comic, motivational speaker and two-time cancer survivor Mack Dryden inspires and entertains at conferences and celebrations nationwide.